- Home
- BMEZ
as 07-26-2024 4:00pm EST
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.6B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 391.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 0.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.93 - $16.95 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of BlackRock Health Sciences Term Trust of Beneficial Interest (BMEZ)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Apr 1 '24 | Buy | $16.33 | 46,421 | $758,054.93 | 20,538,431 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Mar 28 '24 | Buy | $16.33 | 16,297 | $266,130.01 | 20,492,010 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Mar 26 '24 | Buy | $16.32 | 129,372 | $2,111,351.04 | 20,475,713 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Mar 6 '24 | Buy | $16.28 | 13,781 | $224,354.68 | 20,346,341 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 29 '24 | Buy | $16.30 | 46,958 | $765,415.40 | 20,220,510 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 29 '24 | Buy | $16.49 | 112,050 | $1,847,704.50 | 20,332,560 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 27 '24 | Buy | $16.45 | 56,448 | $928,569.60 | 20,132,252 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 27 '24 | Buy | $16.46 | 41,300 | $679,798.00 | 20,173,552 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 23 '24 | Buy | $16.31 | 111,946 | $1,825,839.26 | 19,961,874 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 23 '24 | Buy | $16.34 | 113,930 | $1,861,616.20 | 20,075,804 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 21 '24 | Buy | $16.07 | 116,688 | $1,875,176.16 | 19,694,996 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 21 '24 | Buy | $16.13 | 154,932 | $2,499,053.16 | 19,849,928 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 16 '24 | Buy | $15.87 | 74,566 | $1,183,362.42 | 19,385,011 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 16 '24 | Buy | $15.92 | 193,297 | $3,077,288.24 | 19,578,308 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 13 '24 | Buy | $15.85 | 120,820 | $1,914,997.00 | 19,268,983 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 13 '24 | Buy | $15.82 | 41,462 | $655,928.84 | 19,310,445 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 8 '24 | Buy | $16.08 | 83,360 | $1,340,428.80 | 19,148,163 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 8 '24 | Buy | $15.97 | 122,094 | $1,949,841.18 | 19,064,803 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 8 '24 | Buy | $15.82 | 82,426 | $1,303,979.32 | 18,942,709 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 6 '24 | Buy | $15.71 | 69,870 | $1,097,657.70 | 18,759,929 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 6 '24 | Buy | $15.81 | 100,354 | $1,586,596.74 | 18,860,283 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 2 '24 | Buy | $15.60 | 53,462 | $834,007.20 | 18,596,092 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Feb 2 '24 | Buy | $15.56 | 93,967 | $1,462,126.52 | 18,690,059 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Jan 31 '24 | Buy | $15.50 | 134,564 | $2,085,742.00 | 18,506,906 | SEC Form 4 |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Jan 31 '24 | Buy | $15.62 | 35,724 | $558,008.88 | 18,542,630 | SEC Form 4 |
Latest BlackRock Health Sciences Term Trust of Beneficial Interest News
BMEZ Breaking Stock News: Dive into BMEZ Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Saba Capital Corrects BlackRock’s Intentionally False and Misleading 2024 Annual Meeting Results
Business Wire
a month ago
ISS Endorses ALL of Saba Capital’s Nominees at the BlackRock Science and Technology Term Trust and BlackRock California Municipal Income Trust
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
a month ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Business Wire
a month ago
Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
Business Wire
a month ago
Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
GlobeNewswire
a month ago
SEALSQ to Launch Two New Quantum Resistant Chips
Compare BMEZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.